Related Experiment Video

Updated: Jun 19, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in

Jin-Hai Chang1, Naoya Kato, Ryosuke Muroyama

  • 1Department of Gastroenterology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

Liver International : Official Journal of the International Association for the Study of the Liver
|October 21, 2009
PubMed
Abstract

Insights

Double-stranded RNA-activated protein kinase (PKR) suppresses hepatitis C virus (HCV) replication in its innate state. However, PKR is not essential for interferon therapy, as IFN-alpha effectively inhibits HCV replication in both normal and PKR-knockdown cells.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Double-stranded RNA-activated protein kinase (PKR) is an interferon-stimulated gene.
  • PKR activation by double-stranded RNA, a hepatitis C virus (HCV) intermediate, inhibits viral protein translation.
  • Activated PKR phosphorylates eukaryotic initiation factor-2 alpha.

Purpose of the Study:

  • To investigate the role of PKR in suppressing HCV replication.
  • To establish stable PKR knockdown Huh7 cells using RNA interference.
  • To analyze HCV replication using subgenomic replicons and full-length HCV genomes.

Main Methods:

  • Stable PKR knockdown Huh7 cell line generation via RNA interference.
  • HCV replication assessment using a luciferase reporter subgenomic replicon.
  • Analysis of HCV particle production using a JFH1 full-length genome.

Main Results:

  • PKR knockdown cells showed approximately threefold higher luciferase activity, indicating enhanced subgenomic replicon replication.
  • Stable PKR knockdown cells secreted significantly more HCV particles after full-length genome transfection.
  • Interferon-alpha suppressed subgenomic replicon replication in both cell types, with lower efficacy in PKR knockdown cells at low concentrations.

Conclusions:

  • PKR plays a significant role in suppressing HCV replication during innate immune responses.
  • PKR is not essential for the efficacy of interferon therapy against HCV.
  • Interferon-alpha demonstrates potent antiviral activity against HCV regardless of PKR status at sufficient concentrations.

More Related Videos

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...